Nanotechnology in Cancer Treatment: Innovative Approaches to Overcoming Drug Resistance in Tumors
Abstract
Nanotechnology has emerged as a groundbreaking approach in oncology, offering innovative solutions to one of the most significant challenges in cancer treatment: drug resistance. This literature review explores the role of nanotechnology in overcoming multidrug resistance (MDR) in tumors, focusing on the use of nanoparticles for targeted drug delivery, gene therapy, and immunotherapy. By penetrating biological barriers and modulating the tumor microenvironment, nanocarriers enhance the efficacy of anticancer agents while minimizing side effects. Additionally, this review provides a comprehensive analysis of recent clinical trials, offering insights into the real-world effectiveness of nanotechnology-based treatments. Ethical, regulatory challenges, and nanotoxicity are discussed to ensure the safe translation of nanomedicine to clinical practice. The review concludes with future directions in personalized nanomedicine, highlighting nanotechnology’s transformative potential in revolutionizing cancer treatment and improving patient outcomes by addressing the pervasive issue of drug resistance.
Keywords: nanotechnology, drug resistance, nanoparticles, targeted drug delivery, cancer therapy.
Full Text:
PDFReferences
Aloss, K., and Hamar, P., 2023, Recent Preclinical and Clinical Progress in Liposomal Doxorubicin, Pharmaceutics, 15(3), 893. CrossRef
Alvarez, N., and Sevilla, A., 2024, Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies, International Journal of Molecular Sciences, 25(2), 1023. CrossRef
Báez, D.F., 2023, Graphene-Based Nanomaterials for Photothermal Therapy in Cancer Treatment, Pharmaceutics, 15(9), 2286. CrossRef
Bhatia, S.N., Chen, X., Dobrovolskaia, M.A., and Lammers, T., 2022, Cancer nanomedicine, Nature reviews. Cancer, 22(10), 550–556. CrossRef
Buabeid, M.A., Arafa, E.A., and Murtaza, G., 2020, Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy, Journal of Immunology Research, 2020, 9624532. CrossRef
Bukhari, S.N.A., 2022, Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials, Pharmaceutics, 14(4), 866. CrossRef
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., and Gong, T., 2023, Nanomedicine in cancer therapy, Signal Transduction and Targeted Therapy, 8, 293. CrossRef
Fang, J., Liu, Y., Chen, Y., Ouyang, D., Yang, G., and Yu, T., 2018, Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergisti chemo-photothermal therapy, International Journal of Nanomedicine, 13, 5991–6007. CrossRef
Fojo, T., 2007, Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs, Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy, 10(1-2), 59–67. CrossRef
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., and Singhal, S.S., 2024, Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells, Cancers, 16(13), 2478. CrossRef
Greaves, M., and Maley, C.C., 2012, Clonal evolution in cancer, Nature, 481(7381), 306–313. CrossRef
Han, H.S., and Choi, K.Y., 2021, Advances in Nanomaterial-Mediated Photothermal Cancer Therapies: Toward Clinical Applications, Biomedicines, 9(3), 305. CrossRef
Hauser, M., Li, G., and Nowack, B., 2019, Environmental hazard assessment for polymeric and inorganic nanobiomaterials used in drug delivery, Journal of Nanobiotechnology, 17(1), 56. CrossRef
Hu, C.M., and Zhang, L., 2012, Nanoparticle-based combination therapy toward overcoming drug resistance in cancer, Biochemical Pharmacology, 83(8), 1104–1111. CrossRef
Huang, J., Zhou, Y., Li, J., Lu, A., and Liang, C., 2022, CRISPR/Cas systems: Delivery and application in gene therapy, Frontiers in Bioengineering and Biotechnology, 10, 942325. CrossRef
Joudeh, N., and Linke, D., 2022, Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists, Journal of Nanobiotechnology, 20(1), 262. CrossRef
Junyaprasert, V.B., and Thummarati, P., 2023, Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy, Pharmaceutics, 15(9), 2216. CrossRef
Kim, H.S., and Lee, D.Y., 2018, Near-Infrared- Responsive Cancer Photothermal and Photodynamic Therapy Using Gold Nanoparticles, Polymers, 10(9), 961. CrossRef
Li, L., Hu, S., and Chen, X., 2018, Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities, Biomaterials, 171, 207–218. CrossRef
Lowe, S.W., Ruley, H.E., Jacks, T., and Housman, D.E., 1993, p53-dependent apoptosis modulates the cytotoxicity of anticancer agents, Cell, 74(6), 957–967. CrossRef
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., et al., 2024, Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy, Journal of Hematology & Oncology, 17(1), 16. CrossRef
Majidinia, M., Mirza-Aghazadeh-Attari, M., Rahimi, M., Mihanfar, A., Karimian, A., Safa, A., and Yousefi, B., 2020, Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons, IUBMB Life, 72(5), 855–871. CrossRef
Mitchell, M.J., Billingsley, M.M., Haley, R.M., Wechsler, M.E., Peppas, N.A., and Langer, R., 2021, Engineering precision nanoparticles for drug delivery, Nature reviews Drug discovery, 20(2), 101–124. CrossRef
Mosleh-Shirazi, S., Abbasi, M., Moaddeli, M.R., Vaez, A., Shafiee, M., Kasaee, S.R., et al., 2022, Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview, Nanotheranostics, 6(4), 400–423. CrossRef
Nanoethics: It’s time for big thinking about nanomedicine, (2019, April 18), American Medical Association. https://www.ama-assn. org/delivering-care/ethics/nanoethics-it-s-time-big-thinking-about-nanomedicine
Nasir, A., Khan, A., Li, J., Naeem, M., Khalil, A.A.K., Khan, K., and Qasim, M, 2021, Nanotechnology, A Tool for Diagnostics and Treatment of Cancer, Current Topics in Medicinal Chemistry, 21(15), 1360–1376. CrossRef
Nieto Montesinos, R., Béduneau, A., Pellequer, Y., and Lamprecht, A., 2012, Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes, Journal of Controlled Release: Official Journal of the Controlled Release Society, 161(1), 50–61. CrossRef
Nowell, P.C., 1976, The clonal evolution of tumor cell populations, Science (New York, N.Y.), 194(4260), 23–28. CrossRef
Phi, L.T.H., Sari, I.N., Yang, Y.G., Lee, S.H., Jun, N., Kim, K. S., et al., 2018, Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment, Stem Cells International, 2018, 5416923. CrossRef
Pinho, S., Ferreira-Gonçalves, T., Lopes, J., Amaral, M.N., Viana, A.S., Coelho, J.M.P., et al., 2024, A Step Forward for the Treatment of Localized Prostate Cancer Using Gold Nanoparticles Combined with Laser Irradiation, International Journal of Molecular Sciences, 25(8), 4488. CrossRef
Selvaraja, V.K., and Gudipudi, D.K., 2020, Fundamentals to clinical application of nanoparticles in cancer immunotherapy and radiotherapy, Ecancermedicalscience, 14, 1095. CrossRef
Severi, A.A., and Akbari, B., 2024, CRISPR-Cas9 delivery strategies and applications: Review and update, Genesis (New York, N.Y. : 2000), 62(3), e23598. CrossRef
Shui, M., Chen, Z., Chen, Y., Yuan, Q., Li, H., Vong, C.T., et al., 2023, Engineering polyphenol-based carriers for nucleic acid delivery, Theranostics, 13(10), 3204–3223. CrossRef
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., et al., 2023, Smart nanoparticles for cancer therapy, Signal Transduction and Targeted Therapy, 8, 418. CrossRef
Synold, T.W., Dussault, I., and Forman, B.M., 2001, The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux, Nature Medicine, 7(5), 584–590. CrossRef
Torgovnick, A., and Schumacher, B., 2015, DNA repair mechanisms in cancer development and therapy, Frontiers in Genetics, 6, 157. CrossRef
Wahab, R., Kaushik, N., Khan, F., Kaushik, N.K., Lee, S.J., Choi, E.H., and Al-Khedhairy, A.A., 2019, Gold quantum dots impair the tumorigenic potential of glioma stem-like cells via β-catenin downregulation in vitro, International Journal of Nanomedicine, 14, 1131–1148. CrossRef
Yoo, J., Park, C., Yi, G., Lee, D., and Koo, H., 2019, Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems, Cancers, 11(5), 640. CrossRef
Yu, B., Tai, H.C., Xue, W., Lee, L.J., and Lee, R.J., 2010, Receptor targeted nanocarriers for therapeutic delivery to cancer, Molecular Membrane Biology, 27(7), 286–298. CrossRef
Zhang, M., Kim, J.A., and Huang, A.Y., 2018, Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles, Frontiers in Immunology, 9, 341. CrossRef
DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev15iss2pp162-174
Copyright (c) 2024 Indonesian Journal of Cancer Chemoprevention
Indexed by:
Indonesian Society for Cancer Chemoprevention
